Mass Spectrometry for the Study of Autism and Neurodevelopmental Disorders

Area of Science:

• Neuroscience
• Biochemistry
• Genetics

Background:

• Mass spectrometry (MS) is a powerful analytical technique increasingly applied to central nervous system (CNS) disorders.
• Autism spectrum disorders (ASDs) are complex neurodevelopmental conditions with a growing body of research utilizing MS.
• Early MS studies in ASD focused on external toxins, but current research emphasizes endogenous protein alterations.

Purpose of the Study:

• To review the application of mass spectrometry (MS) in the study of autism spectrum disorders (ASDs).
• To highlight the shift towards proteomic analysis for understanding endogenous protein changes in ASD.
• To discuss the use of MS in investigating related neurodevelopmental disorders, including Fragile X syndrome (FXS) and Smith-Lemli-Opitz Syndrome (SLOS).

Main Methods:

• Proteomic analysis using mass spectrometry (MS) to identify and quantify proteins.
• Application of MS-based proteomics to study biological samples relevant to ASD.
• Comparative proteomic studies in neurodevelopmental disorders, including genetic syndromes associated with ASD.

Main Results:

• MS enables the detailed investigation of endogenous protein profiles in ASD.
• Proteomic analysis reveals molecular differences associated with ASD.
• MS is a valuable tool for studying the proteomic landscape of related genetic syndromes like FXS and SLOS.

Conclusions:

• Mass spectrometry, particularly proteomic analysis, is a key technology for advancing the understanding of ASD.
• This approach provides insights into the molecular mechanisms underlying ASD and associated neurodevelopmental disorders.
• Continued application of MS in ASD research promises to uncover novel biomarkers and therapeutic targets.